Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC

Authors:

Abstract
The present study aimed to clarify the association between macrophages, tumor neo‑vessels and programmed cell death‑ligand 1 (PD‑L1) in the tumor microenvironment and the clinicopathological features of patients with non‑small cell lung cancer (NSCLC), and to explore the prognostic factors of stromal features in NSCLC. To determine this, tissue microarrays containing samples of 92 patients with NSCLC were studied using immunohistochemistry and immunofluorescence. The quantitative data demonstrated that in tumor islets, the number of CD68+ and CD206+ tumor‑associated macrophages (TAMs) was 8‑348 (median, 131) and 2‑220 (median, 52), respectively (P+ and CD206+ TAMs was 23‑412 (median, 169) and 7‑358 (median, 81), respectively (P+ TAMs, and they were significantly correlated (P+ TAMs in tumor stroma and islets and a high density of CD206+ TAMs and PD‑L1 in tumor stroma were associated with worse prognosis (both P+ TAMs in tumor islets and stroma, or CD206+ TAMs in tumor islets and stroma. To the best of our knowledge, the present study was the first to provide a multi‑component combined prognostic survival analysis of different types of macrophages in different regions with tumor neo‑vessels and PD‑L1, which demonstrated the importance of macrophages in tumor stroma.

This publication has 49 references indexed in Scilit: